|
Summary:
Dbs Biosimilars Country:
Austria
Notice Type:
Tender Notice Deadline:
24 Oct 2025 Posting Date:
25 Sep 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Denosumab-Reference: Prolia (Atc Code According To Who: M05Bx04) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Aug 2026 Posting Date:
09 Jul 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Denosumab-Reference: Xgeva (Atc Code According To Who: M05Bx04) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Aug 2026 Posting Date:
09 Jul 2025 |
Biosimilar Manufacturing Services Tenders and Contracts
Biosimilar Manufacturing Services tenders contracts bids and business opportunities -
Healthcare and Medicine